Investment Strategy

Starlink Capital is striving to build strong business partnerships. We are actively looking to expand our product market through the in-licensing and acquisition products (both in-market or in late-stage development)


  • Invest in the development of novel pharmaceutical products – pre-clinical or clinical stages.



  • Strategic investment to obtain licensing rights in China or Greater Asia.